VA Disability benefits are available to veterans with a range of cardiovascular conditions, but navigating the process can be ...

Coronary artery bypass graft (CABG) surgery remains the gold standard treatment for patients with severe atherosclerosis, but ...

aDivision of Cardiac Surgery, St Michael's Hospital–Unity Health Toronto, Toronto, ON, Canada bDivision of Endocrinology and Metabolism, St Michael's Hospital–Unity Health Toronto, Toronto, ON, Canada ...

Basic to Translational Science - - Publication evaluated coronary tissue engineered vessel (CTEV) as a conduit for CABG in a nonhuman primate model - - All implanted CTEVs remained patent through six ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...

Madrid, Spain – 1 September 2025: After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to ...

Japanese scientists have found a way to observe clotting activity in the blood as it happens, without needing invasive procedures. Using a new type of microscope and artificial intelligence, ...

TCT 570: Women Clinical Outcomes of Percutaneous Coronary Intervention in Left Main Coronary Artery Disease at 17-Year Long-Term Follow-Up Receive the the latest news, research, and presentations from ...

In what represents Vienna, Austria-based Valeriot GmbH’s first patenting, its founder and CEO, Michael Flatscher, describes their invention of a device, Autovein, for use in no-touch vein harvesting ...